S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
LON:ADN

1724525 (ADN.L) - ADN Share Forecast, Price & News

Add
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
3.09 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ADN stock logo

About 1724525 (ADN.L) (LON:ADN) Stock

Aberdeen Asset Management PLC is a United Kingdom-based asset manager. The Company operates through asset management for reporting and control purposes. The Company is managed as a single asset management business, with multiple investment strategies of equities, fixed income and property, complemented by a solutions business, which provides multi asset, alternatives and quantitative investment capabilities. These strategies are managed across a range of products, distribution channels and geographic regions. The Company holds investments in seed capital investments, investments in certain Aberdeen-managed funds to hedge deferred fund awards and other investments. The Company operates in approximately 20 countries. Its operations span across Asia Pacific, Australia, the United Kingdom, the United States, the Middle East and Europe, among others.

Receive ADN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 1724525 (ADN.L) and its competitors with MarketBeat's FREE daily newsletter.

ADN Stock News Headlines

Advent Technologies Holdings, Inc. (ADN)
Aberdeen Sml.co Regulatory News
Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
Buy THIS stock before Taiwan is attacked
... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.
Don't Forget Silver And Platinum
Coronavirus: Looking To The Long Term
See More Headlines
Receive ADN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 1724525 (ADN.L) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Optical Instrument & Lens Manufacturing
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Martin James Gilbert LL.D.
    M.D., Chief Executive, Executive Director
  • Andrew A. Laing
    Deputy Chief Executive, Executive Director
  • Bever Hendry
    Co-Head of Americas and Chief Financial Officer
  • W. J. Rattray
    Finance Director, Executive Director
  • Martin Jennings
    Chief Executive Officer Parmenion and Head of Aberdeen Digital
  • Avril McLean
    Chief Technology Officer
  • Gordon H. Brough
    General Counsel
  • Hugh Young
    Managing Director of Aberdeen Asset Management Asia, Executive Director
  • Roderick MacLeod MacRae
    Group Head - Risk, Executive Director
  • Kerry Christie
    Global Head - Human Resources













ADN Stock - Frequently Asked Questions

What other stocks do shareholders of 1724525 (ADN.L) own?
What is 1724525 (ADN.L)'s stock symbol?

1724525 (ADN.L) trades on the London Stock Exchange (LON) under the ticker symbol "ADN."

How do I buy shares of 1724525 (ADN.L)?

Shares of ADN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

How can I contact 1724525 (ADN.L)?

1724525 (ADN.L)'s mailing address is 10 Queens Terrace, ABERDEEN, AB10 1XL, United Kingdom. The official website for the company is www.aberdeen-asset.com. The company can be reached via phone at +44-1224-631999.

This page (LON:ADN) was last updated on 3/27/2023 by MarketBeat.com Staff